Cross-Species Analyses Identify Dlgap2 as a Regulator of Age-Related Cognitive Decline and Alzheimer's Dementia.
Alzheimer’s
Diversity Outbred
Dlgap2
GWAS
aging
cognition
genetic diversity
resilience
spines
susceptibility
translational
Journal
Cell reports
ISSN: 2211-1247
Titre abrégé: Cell Rep
Pays: United States
ID NLM: 101573691
Informations de publication
Date de publication:
01 09 2020
01 09 2020
Historique:
received:
16
05
2019
revised:
10
02
2020
accepted:
07
08
2020
entrez:
3
9
2020
pubmed:
3
9
2020
medline:
29
5
2021
Statut:
ppublish
Résumé
Genetic mechanisms underlying age-related cognitive decline and dementia remain poorly understood. Here, we take advantage of the Diversity Outbred mouse population to utilize quantitative trait loci mapping and identify Dlgap2 as a positional candidate responsible for modifying working memory decline. To evaluate the translational relevance of this finding, we utilize longitudinal cognitive measures from human patients, RNA expression from post-mortem brain tissue, data from a genome-wide association study (GWAS) of Alzheimer's dementia (AD), and GWAS results in African Americans. We find an association between Dlgap2 and AD phenotypes at the variant, gene and protein expression, and methylation levels. Lower cortical DLGAP2 expression is observed in AD and is associated with more plaques and tangles at autopsy and faster cognitive decline. Results will inform future studies aimed at investigating the cross-species role of Dlgap2 in regulating cognitive decline and highlight the benefit of using genetically diverse mice to prioritize novel candidates.
Identifiants
pubmed: 32877673
pii: S2211-1247(20)31080-9
doi: 10.1016/j.celrep.2020.108091
pmc: PMC7502175
mid: NIHMS1627849
pii:
doi:
Substances chimiques
DLGAP2 protein, human
0
Nerve Tissue Proteins
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
108091Subventions
Organisme : NIA NIH HHS
ID : P30 AG038070
Pays : United States
Organisme : NIDA NIH HHS
ID : P50 DA039841
Pays : United States
Organisme : NIA NIH HHS
ID : U24 AG021886
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG054719
Pays : United States
Organisme : NIA NIH HHS
ID : P50 AG008702
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG054180
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG017917
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG057911
Pays : United States
Organisme : NIA NIH HHS
ID : F31 AG050357
Pays : United States
Organisme : NIA NIH HHS
ID : RF1 AG054080
Pays : United States
Organisme : NIA NIH HHS
ID : U01 AG061357
Pays : United States
Organisme : NIA NIH HHS
ID : P30 AG066462
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG059716
Pays : United States
Organisme : NIA NIH HHS
ID : K23 AG062750
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG064614
Pays : United States
Organisme : NIA NIH HHS
ID : K01 AG049164
Pays : United States
Organisme : NIA NIH HHS
ID : RF1 AG057470
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG015819
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG057914
Pays : United States
Organisme : NIA NIH HHS
ID : RF1 AG057471
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG061800
Pays : United States
Organisme : NIA NIH HHS
ID : RF1 AG062181
Pays : United States
Organisme : NIA NIH HHS
ID : U01 AG061356
Pays : United States
Organisme : NIA NIH HHS
ID : U01 AG032984
Pays : United States
Organisme : NIMH NIH HHS
ID : F31 MH067445
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG036042
Pays : United States
Organisme : NIA NIH HHS
ID : P30 AG010161
Pays : United States
Organisme : NIA NIH HHS
ID : U01 AG052410
Pays : United States
Organisme : NIA NIH HHS
ID : RF1 AG063755
Pays : United States
Informations de copyright
Copyright © 2020 The Author(s). Published by Elsevier Inc. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of Interests C.C.K. and S.M.N. have filed a related patent application. The other authors declare no competing interests.